Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Spring Sale
Enjoy this offer
* See conditions under "Our services"

Valuation: Kyowa Kirin Co., Ltd.

Capitalization 1,202B 7.57B 6.54B 5.91B 5.65B 10.3B 698B 10.59B 69.82B 27.83B 334B 28.41B 27.81B P/E ratio 2025
19.7x
P/E ratio 2026 * 14.5x
Enterprise value 990B 6.23B 5.39B 4.86B 4.65B 8.48B 575B 8.72B 57.49B 22.92B 275B 23.39B 22.9B EV / Sales 2025
2.66x
EV / Sales 2026 * 1.84x
Free-Float
41.96%
Yield 2025
2.45%
Yield 2026 * 2.94%
1 day-0.30%
1 week+5.82%
Current month-20.62%
1 month-10.88%
3 months-10.32%
6 months-6.49%
Current year-9.38%
1 week 2,136
Extreme 2136
2,358
1 month 2,109
Extreme 2109
2,912
Current year 2,109
Extreme 2109
2,912
1 year 2,034
Extreme 2034
2,912
3 years 2,025
Extreme 2025
3,350
5 years 2,025
Extreme 2025
4,240
10 years 1,412
Extreme 1412
4,240
Manager TitleAgeSince
Chief Executive Officer 66 31/03/2011
President - 27/03/2025
Director of Finance/CFO - 31/03/1986
Director TitleAgeSince
Chairman 66 28/02/2025
Director/Board Member 70 28/02/2021
Director/Board Member 70 28/02/2022
Change 5d. change 1-year change 3-years change Capi.($)
-0.37%+5.82%+4.04%-19.42% 7.58B
0.00%-9.79%-17.29%-35.93% 56.2B
-1.96%-5.06%+8.19%+59.69% 8B
-1.20%+1.23%-6.09%+58.17% 5.34B
0.00%+6.60%-17.85%+100.44% 4.99B
-0.84%-4.25%+66.21%+52.19% 3.09B
-1.15%+5.09%-13.60%-18.45% 2.72B
-6.67%+3.98%+321.37%+563.91% 2.67B
+3.29%+1.62%+43.40%+44.49% 2.51B
-0.09%+3.50%-3.45%+7.47% 2.13B
Average -0.89%-3.88%+38.49%+81.26% 9.52B
Weighted average by Cap. -0.42%-7.98%+1.37%+9.12%

Financials

2025 2026 *
Net sales 484B 3.05B 2.63B 2.38B 2.27B 4.14B 281B 4.26B 28.09B 11.2B 134B 11.43B 11.19B 521B 3.28B 2.83B 2.56B 2.45B 4.46B 302B 4.58B 30.24B 12.05B 145B 12.3B 12.04B
Net income 55.19B 348M 300M 271M 259M 473M 32.05B 486M 3.2B 1.28B 15.32B 1.3B 1.28B 83.4B 525M 454M 410M 392M 714M 48.42B 734M 4.84B 1.93B 23.15B 1.97B 1.93B
Net Debt -212B -1.34B -1.16B -1.04B -997M -1.82B -123B -1.87B -12.33B -4.91B -58.95B -5.02B -4.91B -242B -1.52B -1.32B -1.19B -1.14B -2.07B -140B -2.13B -14.03B -5.59B -67.11B -5.71B -5.59B
Logo Kyowa Kirin Co., Ltd.
Kyowa Kirin Co Ltd is a Japan-based company engaged in the manufacture and sale of medical drugs. The Company operates in Pharmaceuticals business segment. The Company engages in the research, development, manufacture, sale, and import & export of prescription pharmaceuticals. The Company has drug discovery technologies in antibody therapeutics and hematopoietic stem cell gene therapy. Its development pipeline includes AMG531 for aplastic anemia untreated with immunosuppressive therapy, KHK4083/AMG 451 for moderate to severe atopic dermatitis, KHK4083/AMG 451 for moderate to severe asthma, and KK2845 for acute myeloid leukemia and others. In addition, through its subsidiaries, the Company develops, manufactures, markets, and contracts out biosimilar pharmaceuticals, and engages in wholesale and retail sales and insurance agency business. The Company operates in Japan and overseas.
Employees
5,669
Date Price Change Volume
12/03/26 2,288.50 ¥ -0.37% 648,900
11/03/26 2,297.00 ¥ +0.68% 1,810,500
10/03/26 2,281.50 ¥ +3.63% 2,212,200
09/03/26 2,201.50 ¥ -2.22% 2,825,800
06/03/26 2,251.50 ¥ +4.04% 2,956,000
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
11
Last Close Price
2,297.00JPY
Average target price
2,177.27JPY
Spread / Average Target
-5.21%

Quarterly revenue - Rate of surprise

SPRING SALE -40%: The Best Tools Reserved for Subscribers to Identify Tomorrow's Top Investments!
d
:
:
BENEFIT NOW